Legend: Boston Convention & Exhibition Center = CC, Westin Boston Waterfront = W, Seaport Boston Hotel = S
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 147 * ! | Mon, 8/4/2014, 10:30 AM - 12:20 PM | CC-151B | |
| PRO Analysis: From Meaningful Use to Interpretation — Invited Papers | |||
| Health Policy Statistics Section | |||
| Organizer(s): Kelly Zou, Pfizer | |||
| Chair(s): Kelly Zou, Pfizer | |||
| 10:35 AM | Pro Analysis: From Meaningful Use to Interpretation — Tito Mendoza, MD Anderson Cancer Center ; Valen Johnson, Texas A&M | ||
| 11:00 AM | Use and Interpretation of Pros in Early Phase Cancer Clinical Trials — Amylou Dueck, Mayo Clinic ; Pamela Atherton, Mayo Clinic ; Rui Qin, Mayo Clinic ; Jeff Sloan, Mayo Clinic | ||
| 11:25 AM | Mediation Models in Patient-Reported Outcomes Research — Joseph C. Cappelleri, Pfizer ; Kelly Zou, Pfizer ; Andrew G. Bushmakin, Pfizer ; Jose Ma. J. Alvir, Pfizer ; Demissie Alemayehu, Pfizer ; Tara Symonds, Pfizer | ||
| 11:50 AM | Pragmatic Trials Using Pro Data Found in Electronic Health Records — Laura Lee Johnson, NIH/NCCAM | ||
| 12:15 PM | Floor Discussion | ||
2014 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Professional Development program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.